Journal article
Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: An individual participant data meta-Analysis
N Schouten, R Wang, H Torrance, T Van Tilborg, E Bastu, C Bergh, T D'Hooghe, J Friis Petersen, K Jayaprakasan, Y Khalaf, E Klinkert, A La Marca, L Vuong, L LapensCrossed D Sign©e, S Lensen, Å Magnusson, A Allegra, A Nyboe Andersen, S Oudshoorn, B Popovic-Todorovic Show all
Human Reproduction Update | OXFORD UNIV PRESS | Published : 2025
Open access
Abstract
BACKGROUND: The ovarian response to gonadotropin stimulation varies widely among women, and could impact the probability of live birth as well as treatment risks. Many studies have evaluated the impact of different gonadotropin starting doses, mainly based on predictive variables like ovarian reserve tests (ORT) including anti-Müllerian hormone (AMH), antral follicle count (AFC), and basal follicle-stimulating hormone (bFSH). A Cochrane systematic review revealed that individualizing the gonadotropin starting dose does not affect efficacy in terms of ongoing pregnancy/live birth rates, but may reduce treatment risks such as the development of ovarian hyperstimulation syndrome (OHSS). An indi..
View full abstractGrants
Awarded by Merck Healthcare KGaA
Funding Acknowledgements
The Netherlands Organization for Health Research and Development (ZonMW number 848101001).